Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Dev Neurosci ; 83(3): 297-306, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-37016584

RESUMEN

Poor nutritional quality in the early stages of development is associated with neurological diseases in adulthood. Studies showed that obesity-induced oxidative stress contributes to the genesis of neurological diseases through dysregulation of the brainstem and hypothalamus. Fluoxetine (Fx) is an antidepressant member in the family of selective serotonin reuptake inhibitors (SSRI) that can induce positive effects by reducing oxidative damage in brain tissues. We aimed to evaluate the late effect of Fx in the brainstem and hypothalamus of overnourished rats during development. Male Wistar rats, after birth, were randomly divided into the normal-nourished group (N, n = 9) and the overnourished group (O, n = 3). On the 39th day of life, the groups were subdivided into normofed, and the overnourished group treated or not with fluoxetine (10 mg/kg daily) (NF, NV, OF, and OV). All groups were treated from the 39th to the 59th day of life, and within 90 days, the tissues were collected for oxidative stress analysis. Briefly, our results showed that Fx treatment induced a tissue-dependent long-lasting effect in overfed animals, increasing the enzymatic defense (i.e., CAT and GST activity) in the hypothalamus, but more intensive, increasing the non-enzymatic defense (i.e., Total Thiols and GSH levels) in the brainstem. Overall, our study suggests that serotonin modulation at the final stage of brain development causes a long-lasting impact on brain structures in overfed rats at a different mode.


Asunto(s)
Fluoxetina , Estrés Oxidativo , Ratas , Animales , Masculino , Fluoxetina/farmacología , Ratas Wistar , Hipotálamo , Tronco Encefálico
2.
Eur J Pharmacol ; 881: 173200, 2020 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-32445706

RESUMEN

Nutritional imbalance in early life may disrupt the hypothalamic control of energy homeostasis and increase the risk of metabolic disease. The hypothalamic serotonin (5-hydroxytryptamine; 5-HT) system based in the hypothalamus plays an important role in the homeostatic control of energy balance, however the mechanisms underlying the regulation of energy metabolism by 5-HT remain poorly described. Several crucial mitochondrial functions are altered by mitochondrial stress. Adaptations to this stress include changes in mitochondrial multiplication (i.e, mitochondrial biogenesis). Due to the scarcity of evidence regarding the effects of serotonin reuptake inhibitors (SSRI) such as fluoxetine (FLX) on mitochondrial function, we sought to investigate the potential contribution of FLX on changes in mitochondrial function and biogenesis occurring in overfed rats. Using a neonatal overfeeding model, male Wistar rats were divided into 4 groups between 39 and 59 days of age based on nutrition and FLX administration: normofed + vehicle (NV), normofed + FLX (NF), overfed + vehicle (OV) and overfed + FLX (OF). We found that neonatal overfeeding impaired mitochondrial respiration and increased oxidative stress biomarkers in the hypothalamus. FLX administration in overfed rats reestablished mitochondrial oxygen consumption, increased mitochondrial uncoupling protein 2 (Ucp2) expression, reduced total reactive species (RS) production and oxidative stress biomarkers, and up-regulated mitochondrial biogenesis-related genes. Taken together our results suggest that FLX administration in overfed rats improves mitochondrial respiratory chain activity and oxidative balance and increases the transcription of genes employed in mitochondrial biogenesis favoring mitochondrial energy efficiency in response to early nutritional imbalance.


Asunto(s)
Fármacos Antiobesidad/farmacología , Metabolismo Energético/efectos de los fármacos , Fluoxetina/farmacología , Hipotálamo/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Biogénesis de Organelos , Hipernutrición/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Factores de Edad , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Animales Recién Nacidos , Animales Lactantes , Hipotálamo/metabolismo , Hipotálamo/patología , Hipotálamo/fisiopatología , Masculino , Mitocondrias/genética , Mitocondrias/metabolismo , Mitocondrias/patología , Estado Nutricional , Hipernutrición/metabolismo , Hipernutrición/patología , Hipernutrición/fisiopatología , Oxidación-Reducción , Consumo de Oxígeno , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Transcripción Genética , Proteína Desacopladora 2/genética , Proteína Desacopladora 2/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA